Literature DB >> 30758725

α/β-Chimera peptide synthesis with cyclic β-sugar amino acids: the efficient coupling protocol.

Adrienn Nagy1, Viktória Goldschmidt Gőz2, István Pintér1, Viktor Farkas2, András Perczel3,4.   

Abstract

The synthesis of α/β-chimeras comprises peptide bond formation from α- to β-, from β- to β-, and from β- to α-amino acid residues. The fine-tuned solid phase synthesis of -GXXG- chimera peptides containing the simplest achiral α-amino acid glycine and two cyclic SAAs of different ring size [X denoting cyclic β-Sugar Amino Acids (β-SAA)] is reported, variants containing Fmoc-RibAFU(ip)-OH a furanoid-, and Fmoc-GlcAPU(Me)-OH a pyranoid-type structural "Lego-element". Systematic search for the best coupling strategy with both H-β-SAA-OHs is described, including the comparison of the different coupling reagents and conditions. Selecting the optimal reagent (from commonly used PyBOP, HATU and HOBt) was assisted by time-resolved 1H-NMR: formation and stability of the Fmoc protected active esters were compared. We found that PyBOP is the best choice for successfully coupling both H-β-SAA-OH prototypes. The present comparative results open a reasonable route for building efficiently various -β-SAA- containing homo- and heterooligomers.

Entities:  

Keywords:  Carbopeptoid; Foldamers; PyBOP; Sugar active ester; Sugar amino acids

Mesh:

Substances:

Year:  2019        PMID: 30758725     DOI: 10.1007/s00726-019-02702-9

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  2 in total

1.  Synthesis of chimera oligopeptide including furanoid β-sugar amino acid derivatives with free OHs: mild but successful removal of the 1,2-O-isopropylidene from the building block.

Authors:  Kim Hoang Yen Duong; Viktória Goldschmidt Gőz; István Pintér; András Perczel
Journal:  Amino Acids       Date:  2021-02-09       Impact factor: 3.520

2.  Unwanted hydrolysis or α/β-peptide bond formation: how long should the rate-limiting coupling step take?

Authors:  Viktória Goldschmidt Gőz; Adrienn Nagy; Viktor Farkas; Ernő Keszei; András Perczel
Journal:  RSC Adv       Date:  2019-09-27       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.